WuXi AppTec aims for 50 billion revenue by 2026, using real money to combat market volatility

WuXi AppTec (603259.SH/2359.HK) is building certainty in a volatile market by delivering record shareholder returns and pursuing ambitious growth targets. Based on its outstanding performance in 2025, with net profit attributable to shareholders surging 102.65% year-on-year to RMB 19.151 billion, and adhering to its consistent dividend payout ratio of approximately 30%, the company's total cash dividend for 2025 will exceed RMB 5.7 billion. Coupled with its planned interim dividend for 2026, the total dividend for 2026 is set to break its all-time record since listing. Meanwhile, backed by a historically high order backlog of nearly RMB 58 billion and a clear growth path, the company demonstrates strong momentum to achieve an RMB 50 billion revenue target in 2026, confronting market challenges with a combined strategy of "high returns + high growth."

Supporting this "generosity" is an impeccable 2025 "report card": the company's full-year revenue is expected to reach RMB 45.456 billion, a new historical high. Even its adjusted Non-IFRS net profit attributable to shareholders, which reflects the profitability quality of its core business, achieved a high growth rate of 41.33%. More crucially, the company's full-year adjusted operating cash flow grew 39% year-on-year, with healthy cash flow providing a solid foundation for sustained and substantial shareholder returns. Over the seven years since its listing, the company has cumulatively returned over RMB 20 billion to investors through dividends and share repurchases, establishing a stable, high-return mechanism as its core hallmark.

Against a backdrop of external uncertainty, WuXi AppTec is consolidating market confidence with two "weapons": first, immediate returns in hard cash, with the RMB 5.7 billion dividend directly boosting shareholder returns and enhancing investment appeal; second, clear and foreseeable organic growth, with the RMB 58 billion order backlog and global capacity layout providing high visibility for revenue to approach RMB 50 billion. Furthermore, with the release of its full-year operational targets, a performance-linked, multi-tiered H-share equity incentive plan has been simultaneously implemented, deeply aligning the interests of core talent with the company's long-term value and solidifying the talent foundation for sustained growth.

WuXi AppTec's actions send a clear signal: in a turbulent market, true resilience stems from solid performance, a generous sharing mechanism, and a clear plan for future growth. By delivering on its "hard cash" returns and "strategic ambitions," the company is elevating financial returns into a comprehensive commitment to shareholders, employees, and the industry, continuously reinforcing its leading position and long-term responsibility value as a core infrastructure for pharmaceutical R&D.